MEDVI tirzepatide review

Start a MEDVI tirzepatide comparison with a written offer record. This review separates what our public-page check could establish from the payment details we would still need before calculating a budget.

The captured MEDVI offer page shows $166/month in its headline and $199 in its FAQ. A separate plan page shows $199 for the first four-week supply beside a $299/month plan. Prepaid totals remain unresolved. Its injection card describes compounded tirzepatide; a separate generic GLP-1 tablet card has an unresolved price. These observations do not establish one current bill, renewal rate or tablet-to-injection equivalence.

What belongs in an offer record

Put the offer URL and date at the top of a single sheet. Keep the exact product description beside the price, so a later comparison cannot accidentally borrow one product’s headline and another product’s payment terms. A number without its product and time period is incomplete.

This format also makes a disagreement visible. If the amount on the payment page differs from the offer you saved, do not fix your spreadsheet by choosing whichever figure is lower. Mark the difference as unresolved and ask for a complete written schedule. Our review did not select a plan or verify an individual checkout.

Supply time and payment time need separate columns

As arithmetic, 48 weeks is 336 days. It is not a calendar year. If an offer uses weeks for supply and months for payments, record both units before making a comparison. Spreading a purchase over twelve installments changes the timing of payment; it does not, by itself, tell you how many days of treatment the purchase covers.

For a hypothetical financed purchase of $1,200, twelve equal installments would be $100. That calculation says nothing about the supply duration, an early-exit refund or the balance after cancellation. Those are separate entries. Do not treat an installment as a fresh monthly purchase unless the written agreement actually says so.

Cancellation: keep the applicable wording

MEDVI’s cancellation policy requests 72 hours’ notice before billing. Its unused-multimonth refund passage conflicts with later no-refund wording and the plan consent. We could not establish which provision would govern a particular order.

For your own record, separate three questions: when future billing stops, what happens to an order already underway, and what balance remains payable. Save the confirmation alongside the policy you relied on. We did not contact support or test cancellation, so this review cannot describe the process as easy or promise a refund.

What this review can and cannot settle

We checked public text, not a delivered prescription or a patient experience. We did not establish an assigned prescriber or dispensing pharmacy for a buyer, verify licenses, inspect a medicine label, or test response times. A review of commercial wording should not be read as a rating of clinical care.

The September 18 record in our historical dataset used $399. We retain that record for comparison history; this revision does not turn it into a current quotation. The domain used in the links below is the one captured in this audit. The failed connection to medvi.com did not establish a redirect.

How to use this alongside another offer

Compare the completed offer records over the same proposed dates. First compare the amount needed to start; then compare scheduled future payments and supply. Keep any unresolved cells visible instead of calculating an apparently precise annual saving. The tirzepatide cost guide shows how to make that distinction, and annual versus monthly explores the commitment trade-off.

Our editorial conclusion is to leave MEDVI’s current annual total uncalculated until the selected terms can be reconciled. For safety and legal questions, use the separate compounding guide. Our rating method explains what the historical scores measure.